Opioid agonist therapy discontinuation in British Columbia: a cross-sectional study of people who access harm reduction services
Objectives This study evaluates the prevalence and correlates of opioid agonist therapy (OAT) discontinuation across British Columbia (BC), using a sample of individuals who used substances and accessed harm reduction sites.Design This study uses data from the 2019 cross-sectional Harm Reduction Cli...
Saved in:
Main Authors: | Michael Otterstatter, Jane A Buxton, Kristi Papamihali, Brittany Graham, Lisa Liu, Kimia Ziafat, Bradley Kievit |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-01-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/15/1/e090704.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of Acute Vaccine-Preventable Hepatitis in Individuals with Chronic Hepatitis in British Columbia between 1991 and 2007
by: Lily Fang, et al.
Published: (2011-01-01) -
Comparative effectiveness of urine drug screening strategies alongside opioid agonist treatment in British Columbia, Canada: a population-based observational study protocol
by: Malcolm Maclure, et al.
Published: (2023-05-01) -
Change in Police Attendance at Overdose Events following Implementation of a Police Non-Notification Policy in British Columbia
by: Amiti Mehta, et al.
Published: (2022-01-01) -
The Identification of Lynch Syndrome in British Columbia
by: Carol M Cremin, et al.
Published: (2009-01-01) -
Understanding the experiences of young, urban, Indigenous mothers-to-be in British Columbia, Canada
by: Nicole L. A. Catherine, et al.
Published: (2025-01-01)